연구동향 분석
박사

Therapeutic effect of resveratrol on oxidative stress in Graves’ ophthalmopathy orbital fibroblasts

김창염 2015년

논문상세정보
인용/피인용
' Therapeutic effect of resveratrol on oxidative stress in Graves’ ophthalmopathy orbital fibroblasts' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • adipogenesis
  • graves' ophthalmopathy
  • orbital fibroblast
  • oxidative stress
  • reactive oxygen species
  • resveratrol
  • 갑상선안병증
  • 레스베라트롤
  • 산화성 스트레스
  • 안와섬유모세포
  • 지질생성
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,095 0

0.0%

' Therapeutic effect of resveratrol on oxidative stress in Graves’ ophthalmopathy orbital fibroblasts' 의 참고문헌

  • Zarkovic M. The role of oxidative stress on the pathogenesis ofgraves ? disease. J Thyroid Res 2012;2012:302537.
  • Yoon JS, Lee HJ, Choi SH, Chang EJ, Lee SY, Lee EJ. Quercetininhibits IL-1??-induced inflammation, hyaluronan production andadipogenesis in orbital fibroblasts from Graves ? orbitopathy. PLoS One2011;6:e26261.
  • Yoon JS, Lee HJ, Chae MK, Lee SY, Lee EJ. Cigarette smokeextract-induced adipogenesis in Graves ? orbital fibroblasts is inhibitedby quercetin via reduction in oxidative stress. J Endocrinol2013;216:145-56.
  • Weetman AP, Holt ME, Campbell AK, Hall R, McGregor AM.Methimazole and generation of oxygen radicals by monocytes:potential role in immunosuppression. Br Med J (Clin Res Ed)1984;288:518-20.
  • Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW. WhenNRF2 talks, who ?s listening? Antioxid Redox Signal 2010;13:1649-63.29
  • Tsai CC, Wu SB, Kao SC, Kau HC, Lee FL, Wei YH. Theprotective effect of antioxidants on orbital fibroblasts from patientswith Graves ? ophthalmopathy in response to oxidative stress. Mol Vis2013;19:927-34.
  • Tsai CC, Wu SB, Cheng CY, Kao SC, Kau HC, Lee SM, et al.Increased response to oxidative stress challenge in Graves'ophthalmopathy orbital fibroblasts. Mol Vis 2011;17:2782-8.
  • Tsai CC, Kao SC, Cheng CY, Kau HC, Hsu WM, Lee CF, et al.Oxidative stress change by systemic corticosteroid treatment amongpatients having active graves ophthalmopathy. Arch Ophthalmol2007;125:1652-6.
  • Tsai CC, Cheng CY, Liu CY, Kao SC, Kau HC, Hsu WM, et al.Oxidative stress in patients with Graves' ophthalmopathy: relationshipbetween oxidative DNA damage and clinical evolution. Eye (Lond)2009;23:1725-30.
  • Sorisky A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocytedifferentiation in human orbital fibroblasts in primary culture. J ClinEndocrinol Metab 1996;81:3428-31.
  • Shih RH, Cheng SE, Hsiao LD, Kou YR, Yang CM. Cigarettesmoke extract upregulates heme-oxygenase-1 via PKC/NADPHoxidase/ROS/PDGFR/PI3K/Akt pathway in mouse brain endothellialcells. J Neuroinflammation 2011;8:104.
  • Shakibaei M, Harikumar KB, Aggarwal BB. Resveratrol addiction: todie or not to die. Mol Nutr Food Res. 2009;53:115-28.
  • Sakata Y, Zhuang H, Kwansa H, Koehler RC, Dore S. Resveratrolprotects against experimental stroke: putative neuroprotective role ofheme oxygenase 1. Exp Neurol 2010;224:325-9.
  • Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA.Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1adipocytes. Phytother Res 2008;22:1367-71.
  • Quincozes-Santos A, Bobermin LD, Latini A, Wajner M, Souza DO,Gon calves CA, et al. Resveratrol protects C6 astrocyte cell lineagainst hydrogen peroxide-induced oxidative stress through hemeoxygenase 1. PLoS One 2013;8:e64372.
  • Marques FZ, Markus MA, Morris BJ. Resveratrol: cellular actions ofa potent natural chemical that confers a diversity of health benefits.Int J Biochem Cell Biol 2009;41:2125-8.28
  • Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, StahlM, et al. Selenium and the course of mild Graves ? orbitopathy. NEngl J Med 2011;364:1920-31.
  • Lu R, Wang P, Wartofsky L, Sutton BD, Zweier JL, Bahn RS, et al.Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan26production by retro-ocular fibroblasts from normal subjects andGraves ? ophthalmopathy patients. Thyroid 1999;9:297-303.
  • Lehmann GM, Feldon SE, Smith TJ, Phipps RP. Immune mechanismsin thyroid eye disease. Thyroid 2008;18:959-65.
  • Latif R, Morshed SA, Zaidi M, Davies TF. The thyroid-stimulatinghormone receptor: impact of thyroid-stimulating hormone andthyroid-stimulating hormone receptor antibodies on multimerization,cleavage, and signaling. Endocrionol Metab Clin North Am2009;38:319-41.
  • Lacovelli L, Capobianco L, Salvatore L, Sallese M, D ?Ancona GM,De Blasi A. Thyrotropin activates mitogen-activated protein kinasepathway in FRTL-5 by a cAMP-dependent protein kinaseA-independent mechanism. Mol Pharmacol 2001;60:924-33.
  • Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, RahmanI. Resveratrol induces glutathione synthesis by activation of Nrf2 andprotects against cigarette smoke-mediated oxidative stress in humanlung epithelial cells. Am J Physiol Lung Cell Mol Physiol2008;294:L478-88.
  • Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L, Bickers DR, et al.Resveratrol inhibits proliferation of human epidermoid carcinomaA431 cells by modulating MEK1 and AP-1 signalling pathways. ExpDermatol 2006;15:538-46.
  • Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, WoodJG, et al. Small molecule activators of sirtuins extend Saccharomycescerevisiae lifespan. Nature 2003;425:191-6.
  • Hondur A, Konuk O, Dincel AS, Bilgihan A, Unal M, HasanreisogluB. Oxidative stress and antioxidant activity in orbital fibroadiposetissue in Graves' ophthalmopathy. Curr Eye Res 2008;33:421-7.
  • Guerra LN, Rios de Molina Mdel C, Miler EA, Moiguer S, KarnerM, Burdman JA. Antioxidants and methimazole in the treatment ofGraves ? disease: effect on urinary malondialdehyde levels. Clin ChimActa 2005;352:115-20.
  • Green H, Kehinde O. An established preadipose cell line and itsdifferentiation in culture. II. Factors affecting the adipose conversion.Cell 1975; 5:19?27.
  • Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy:implications for prediction, prevention, and treatment. Am JOphthalmol 2006;142:147-53.
  • Fernandez V, Barrientos X, Kipreos K, Valenzuela A, Videla LA.Superoxide radical generation, NADPH oxidase activity, andcytochrome P-450 content of rat liver microsomal fractions in anexperimental hyperthyroid state: relation to lipid peroxidation.Endocrinology 1985;117:496-501.25
  • El-Mowafy AM, White RE. Resveratrol inhibits MAPK activity andnuclear translocation in coronary artery smooth muscle: reversal ofendothelin-1 stimulatory effects. FEBS Lett 1999;451:63-7.
  • Dharmasena A. Selenium supplementation in thyroid associatedophthalmopathy: an update. Int J Ophthalmol 2014;7:365-75.
  • Das S, Tosaki A, Bagchi D, Maulik N, Das DK. Potentiation of asurvival signal in the ischemic heart by resveratrol through p38mitogen-activated protein kinase/mitogen- and stress-activated proteinkinase 1/cAMP response element-binding protein signaling. JPharmacol Exp Ther 2006;317:980-8.30
  • Cawood TJ, Moriarty P, O ?Farrelly C, O ?Shea D. Smoking andthyroid-associated ophthalmopathy: a novel explanation of thebiological link. J Clin Endocrinol Metab 2007;92:59-64.
  • Burch HB, Lahiri S, Bahn RS, Barnes S. Superoxide radicalproduction stimulates retroocular fibroblast proliferation in Graves ?ophthalmopathy. Exp Eye Res 1997;65:311-6.
  • Bednarek J, Wysocki H, Sowinski J. Peripheral parameters ofoxidative stress in patients with infiltrative Graves ? ophthalmopathytreated with corticosteroids. Immunol Lett 2004;93:227-32.
  • Bednarek J, Wysocki H, Sowi?ski J. Oxidative stress peripheralparameters in Graves ? disease: the effect of methimazole treatment inpatients with and without infiltrative ophthalmopathy. Clin Biochem2005;38:13-8.
  • Baglole CJ, Sime PJ, Phipps RP. Cigarette smoke-induced expressionof heme-oxygenase-1 in human lung fibroblasts is regulated byintracellular glutathione. Am J Physiol Lung Cell Mol Physiol2008;295:L624-36.
  • Ahsan H, Ali A, Ali R. Oxygen free radicals and systemicautoimmunity. Clin Exp Immunol 2003;131:398-404.
  • Ademoglu E, Ozbey N, Erbil Y. Determination of oxidative stress inthyroid tissue and plasma of patients with Graves ? disease. Eur JIntern Med 2006;63:414-34.
  • Abalovich M, Llesuy S, Gutierrez S, Repetto M. Peripheralparameters of oxidative stress in Graves ? disease: the effects of27methimazole and 131 iodine treatments. Clin Endocrinol (Oxford)2003;59:321-7.